The Global Mechanical Thrombectomy Devices Market was valued at US$ 760 million in 2021 and is set to witness a healthy growth rate of 6% in the next 5 years. The rising cases of stroke, venous thromboembolism (deep vein thrombosis & pulmonary embolism), approval/launch of novel mechanical thrombectomy devices, favorable clinical trial outcomes with mechanical thrombectomy, and acquisitions by leading players to fortify their vascular portfolio, and treat patients with blood clots are some of the important factors driving the global mechanical thrombectomy devices market.